Results 131 to 140 of about 12,792 (246)
Cushing's disease: pathobiology, diagnosis, and management [PDF]
, 2016 Russell R. Lonser +2 more
openalex +1 more source
Respirology, Volume 31, Issue 1, Page 32-41, January 2026.This study updated safety evidence on ICS and LABA use in pregnant women with asthma. After adjusting confounders, there was no association between ICS or LABA use and adverse fetal outcomes. However, high‐dose ICS exposure was associated with a higher risk of congenital anomalies among ICS users.
Yea‐Chwen Wu +3 more
wiley +1 more source
Selective Hippocampal Subfield Atrophy Mediates Cognitive Decline in Cushing's Disease. [PDF]
Brain BehavFeng Z +9 more
europepmc +1 more source
Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease [PDF]
, 2000 Paolo Colombo +6 more
openalex +1 more source
Dermatologic Therapy, Volume 2026, Issue 1, 2026.Hyperthermia represents a physiological state marked by an elevation in body temperature due to the malfunctioning of thermoregulatory mechanisms. It transpires when the body either generates or absorbs a greater amount of heat than it is capable of expelling.
Zhiya Yang +5 more
wiley +1 more source
Case Report: The experience of using Etomidate in the management of severe Cushing's disease and MRSA bacteraemia in a district general hospital in the United Kingdom [PDF]
, 2018 Stephanie E. Wong +5 more
openalex +1 more source
Animal Models and Treatment of Pulmonary Fibrosis: Pharmacogenetic and Nonpharmacogenetic
International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.Pulmonary fibrosis is a significant lung injury caused by multiple factors that profoundly affect the human quality of life. Currently, various animal models are used to understand the aetiology of pulmonary fibrosis and develop treatments. However, only pharmacogenetic models of pulmonary fibrosis have been discussed, and there have been no reviews of
Xingyu Fang +7 more
wiley +1 more source
International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.Objective To assess the efficacy and safety of Chaihu‐Guizhi‐Ganjiang decoction (CGGJD) combined with Danggui‐Shaoyao‐San (DS) in oligomenorrhea treatment. Methods In this prospective open‐label trial, 35 oligomenorrhea patients (30–40 years) received CGGJD‐DS for 3 months, followed by a 2‐month follow‐up.
Mei Yu +5 more
wiley +1 more source
Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas
, 1998 Philippe L. Selvais +3 more
openalex +2 more sources